Global Recombinant FVIII Market Research Report 2024

Report ID: 1540819 | Published Date: Sep 2024 | No. of Page: 93 | Base Year: 2023 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Recombinant FVIII Market Overview
    1.1 Product Overview and Scope of Recombinant FVIII
    1.2 Recombinant FVIII Segment by Type
        1.2.1 Global Recombinant FVIII Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 250 IU/bottle
        1.2.3 500 IU/bottle
        1.2.4 1000 IU/bottle
        1.2.5 2000 IU/bottle
    1.3 Recombinant FVIII Segment by Application
        1.3.1 Global Recombinant FVIII Sales Comparison by Application: (2022-2028)
        1.3.2 Teenagers
        1.3.3 Adults
    1.4 Global Recombinant FVIII Market Size Estimates and Forecasts
        1.4.1 Global Recombinant FVIII Revenue 2017-2028
        1.4.2 Global Recombinant FVIII Sales 2017-2028
        1.4.3 Recombinant FVIII Market Size by Region: 2017 Versus 2021 Versus 2028
2 Recombinant FVIII Market Competition by Manufacturers
    2.1 Global Recombinant FVIII Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Recombinant FVIII Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Recombinant FVIII Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Recombinant FVIII Manufacturing Sites, Area Served, Product Type
    2.5 Recombinant FVIII Market Competitive Situation and Trends
        2.5.1 Recombinant FVIII Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Recombinant FVIII Players Market Share by Revenue
        2.5.3 Global Recombinant FVIII Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Recombinant FVIII Retrospective Market Scenario by Region
    3.1 Global Recombinant FVIII Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Recombinant FVIII Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Recombinant FVIII Market Facts & Figures by Country
        3.3.1 North America Recombinant FVIII Sales by Country
        3.3.2 North America Recombinant FVIII Revenue by Country
        3.3.3 United States
        3.3.4 Canada
    3.4 Europe Recombinant FVIII Market Facts & Figures by Country
        3.4.1 Europe Recombinant FVIII Sales by Country
        3.4.2 Europe Recombinant FVIII Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Recombinant FVIII Market Facts & Figures by Region
        3.5.1 Asia Pacific Recombinant FVIII Sales by Region
        3.5.2 Asia Pacific Recombinant FVIII Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
    3.6 Latin America Recombinant FVIII Market Facts & Figures by Country
        3.6.1 Latin America Recombinant FVIII Sales by Country
        3.6.2 Latin America Recombinant FVIII Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Recombinant FVIII Market Facts & Figures by Country
        3.7.1 Middle East and Africa Recombinant FVIII Sales by Country
        3.7.2 Middle East and Africa Recombinant FVIII Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Recombinant FVIII Historic Market Analysis by Type
    4.1 Global Recombinant FVIII Sales Market Share by Type (2017-2022)
    4.2 Global Recombinant FVIII Revenue Market Share by Type (2017-2022)
    4.3 Global Recombinant FVIII Price by Type (2017-2022)
5 Global Recombinant FVIII Historic Market Analysis by Application
    5.1 Global Recombinant FVIII Sales Market Share by Application (2017-2022)
    5.2 Global Recombinant FVIII Revenue Market Share by Application (2017-2022)
    5.3 Global Recombinant FVIII Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Bayer
        6.1.1 Bayer Corporation Information
        6.1.2 Bayer Description and Business Overview
        6.1.3 Bayer Recombinant FVIII Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Bayer Recombinant FVIII Product Portfolio
        6.1.5 Bayer Recent Developments/Updates
    6.2 Baxter
        6.2.1 Baxter Corporation Information
        6.2.2 Baxter Description and Business Overview
        6.2.3 Baxter Recombinant FVIII Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Baxter Recombinant FVIII Product Portfolio
        6.2.5 Baxter Recent Developments/Updates
    6.3 Comirnaty
        6.3.1 Comirnaty Corporation Information
        6.3.2 Comirnaty Description and Business Overview
        6.3.3 Comirnaty Recombinant FVIII Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Comirnaty Recombinant FVIII Product Portfolio
        6.3.5 Comirnaty Recent Developments/Updates
    6.4 Novo Nordisk
        6.4.1 Novo Nordisk Corporation Information
        6.4.2 Novo Nordisk Description and Business Overview
        6.4.3 Novo Nordisk Recombinant FVIII Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Novo Nordisk Recombinant FVIII Product Portfolio
        6.4.5 Novo Nordisk Recent Developments/Updates
    6.5 Green Cross
        6.5.1 Green Cross Corporation Information
        6.5.2 Green Cross Description and Business Overview
        6.5.3 Green Cross Recombinant FVIII Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 Green Cross Recombinant FVIII Product Portfolio
        6.5.5 Green Cross Recent Developments/Updates
    6.6 Sinocelltech
        6.6.1 Sinocelltech Corporation Information
        6.6.2 Sinocelltech Description and Business Overview
        6.6.3 Sinocelltech Recombinant FVIII Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 Sinocelltech Recombinant FVIII Product Portfolio
        6.6.5 Sinocelltech Recent Developments/Updates
7 Recombinant FVIII Manufacturing Cost Analysis
    7.1 Recombinant FVIII Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Recombinant FVIII
    7.4 Recombinant FVIII Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Recombinant FVIII Distributors List
    8.3 Recombinant FVIII Customers
9 Recombinant FVIII Market Dynamics
    9.1 Recombinant FVIII Industry Trends
    9.2 Recombinant FVIII Market Drivers
    9.3 Recombinant FVIII Market Challenges
    9.4 Recombinant FVIII Market Restraints
10 Global Market Forecast
    10.1 Recombinant FVIII Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Recombinant FVIII by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Recombinant FVIII by Type (2023-2028)
    10.2 Recombinant FVIII Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Recombinant FVIII by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Recombinant FVIII by Application (2023-2028)
    10.3 Recombinant FVIII Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Recombinant FVIII by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Recombinant FVIII by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Recombinant FVIII Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Recombinant FVIII Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Recombinant FVIII Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Recombinant FVIII Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Recombinant FVIII Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Recombinant FVIII Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Recombinant FVIII Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Recombinant FVIII Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Recombinant FVIII Average Price (US$/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Recombinant FVIII Manufacturing Sites and Area Served
    Table 11. Manufacturers Recombinant FVIII Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Recombinant FVIII by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant FVIII as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Recombinant FVIII Sales by Region (2017-2022) & (K Units)
    Table 16. Global Recombinant FVIII Sales Market Share by Region (2017-2022)
    Table 17. Global Recombinant FVIII Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Recombinant FVIII Revenue Market Share by Region (2017-2022)
    Table 19. North America Recombinant FVIII Sales by Country (2017-2022) & (K Units)
    Table 20. North America Recombinant FVIII Sales Market Share by Country (2017-2022)
    Table 21. North America Recombinant FVIII Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Recombinant FVIII Revenue Market Share by Country (2017-2022)
    Table 23. Europe Recombinant FVIII Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Recombinant FVIII Sales Market Share by Country (2017-2022)
    Table 25. Europe Recombinant FVIII Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Recombinant FVIII Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Recombinant FVIII Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Recombinant FVIII Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Recombinant FVIII Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Recombinant FVIII Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Recombinant FVIII Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Recombinant FVIII Sales Market Share by Country (2017-2022)
    Table 33. Latin America Recombinant FVIII Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Recombinant FVIII Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Recombinant FVIII Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Recombinant FVIII Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Recombinant FVIII Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Recombinant FVIII Revenue Market Share by Country (2017-2022)
    Table 39. Global Recombinant FVIII Sales by Type (2017-2022) & (K Units)
    Table 40. Global Recombinant FVIII Sales Market Share by Type (2017-2022)
    Table 41. Global Recombinant FVIII Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Recombinant FVIII Revenue Share by Type (2017-2022)
    Table 43. Global Recombinant FVIII Price by Type (2017-2022) & (US$/Unit)
    Table 44. Global Recombinant FVIII Sales (K Units) by Application (2017-2022)
    Table 45. Global Recombinant FVIII Sales Market Share by Application (2017-2022)
    Table 46. Global Recombinant FVIII Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Recombinant FVIII Revenue Share by Application (2017-2022)
    Table 48. Global Recombinant FVIII Price by Application (2017-2022) & (US$/Unit)
    Table 49. Bayer Corporation Information
    Table 50. Bayer Description and Business Overview
    Table 51. Bayer Recombinant FVIII Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 52. Bayer Recombinant FVIII Product
    Table 53. Bayer Recent Developments/Updates
    Table 54. Baxter Corporation Information
    Table 55. Baxter Description and Business Overview
    Table 56. Baxter Recombinant FVIII Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 57. Baxter Recombinant FVIII Product
    Table 58. Baxter Recent Developments/Updates
    Table 59. Comirnaty Corporation Information
    Table 60. Comirnaty Description and Business Overview
    Table 61. Comirnaty Recombinant FVIII Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 62. Comirnaty Recombinant FVIII Product
    Table 63. Comirnaty Recent Developments/Updates
    Table 64. Novo Nordisk Corporation Information
    Table 65. Novo Nordisk Description and Business Overview
    Table 66. Novo Nordisk Recombinant FVIII Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 67. Novo Nordisk Recombinant FVIII Product
    Table 68. Novo Nordisk Recent Developments/Updates
    Table 69. Green Cross Corporation Information
    Table 70. Green Cross Description and Business Overview
    Table 71. Green Cross Recombinant FVIII Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 72. Green Cross Recombinant FVIII Product
    Table 73. Green Cross Recent Developments/Updates
    Table 74. Sinocelltech Corporation Information
    Table 75. Sinocelltech Description and Business Overview
    Table 76. Sinocelltech Recombinant FVIII Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 77. Sinocelltech Recombinant FVIII Product
    Table 78. Sinocelltech Recent Developments/Updates
    Table 79. Production Base and Market Concentration Rate of Raw Material
    Table 80. Key Suppliers of Raw Materials
    Table 81. Recombinant FVIII Distributors List
    Table 82. Recombinant FVIII Customers List
    Table 83. Recombinant FVIII Market Trends
    Table 84. Recombinant FVIII Market Drivers
    Table 85. Recombinant FVIII Market Challenges
    Table 86. Recombinant FVIII Market Restraints
    Table 87. Global Recombinant FVIII Sales Forecast by Type (2023-2028) & (K Units)
    Table 88. Global Recombinant FVIII Sales Market Share Forecast by Type (2023-2028)
    Table 89. Global Recombinant FVIII Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 90. Global Recombinant FVIII Revenue Market Share Forecast by Type (2023-2028)
    Table 91. Global Recombinant FVIII Sales Forecast by Application (2023-2028) & (K Units)
    Table 92. Global Recombinant FVIII Sales Market Share Forecast by Application (2023-2028)
    Table 93. Global Recombinant FVIII Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 94. Global Recombinant FVIII Revenue Market Share Forecast by Application (2023-2028)
    Table 95. Global Recombinant FVIII Sales Forecast by Region (2023-2028) & (K Units)
    Table 96. Global Recombinant FVIII Sales Market Share Forecast by Region (2023-2028)
    Table 97. Global Recombinant FVIII Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 98. Global Recombinant FVIII Revenue Market Share Forecast by Region (2023-2028)
    Table 99. Research Programs/Design for This Report
    Table 100. Key Data Information from Secondary Sources
    Table 101. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Recombinant FVIII
    Figure 2. Global Recombinant FVIII Market Share by Type in 2021 & 2028
    Figure 3. 250 IU/bottle Product Picture
    Figure 4. 500 IU/bottle Product Picture
    Figure 5. 1000 IU/bottle Product Picture
    Figure 6. 2000 IU/bottle Product Picture
    Figure 7. Global Recombinant FVIII Market Share by Application in 2021 & 2028
    Figure 8. Teenagers
    Figure 9. Adults
    Figure 10. Global Recombinant FVIII Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Recombinant FVIII Market Size (2017-2028) & (US$ Million)
    Figure 12. Global Recombinant FVIII Sales (2017-2028) & (K Units)
    Figure 13. Recombinant FVIII Sales Share by Manufacturers in 2021
    Figure 14. Global Recombinant FVIII Revenue Share by Manufacturers in 2021
    Figure 15. The Global 5 and 10 Largest Recombinant FVIII Players: Market Share by Revenue in 2021
    Figure 16. Recombinant FVIII Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 17. Global Recombinant FVIII Sales Market Share by Region (2017-2022)
    Figure 18. Global Recombinant FVIII Sales Market Share by Region in 2021
    Figure 19. Global Recombinant FVIII Revenue Market Share by Region (2017-2022)
    Figure 20. Global Recombinant FVIII Revenue Market Share by Region in 2021
    Figure 21. United States Recombinant FVIII Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 22. Canada Recombinant FVIII Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. Germany Recombinant FVIII Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. France Recombinant FVIII Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. U.K. Recombinant FVIII Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. Italy Recombinant FVIII Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Russia Recombinant FVIII Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. China Recombinant FVIII Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. Japan Recombinant FVIII Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. South Korea Recombinant FVIII Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. India Recombinant FVIII Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. Australia Recombinant FVIII Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Taiwan Recombinant FVIII Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Indonesia Recombinant FVIII Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Thailand Recombinant FVIII Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Malaysia Recombinant FVIII Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Mexico Recombinant FVIII Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Brazil Recombinant FVIII Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Argentina Recombinant FVIII Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Turkey Recombinant FVIII Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Saudi Arabia Recombinant FVIII Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. UAE Recombinant FVIII Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Sales Market Share of Recombinant FVIII by Type (2017-2022)
    Figure 44. Manufacturing Cost Structure of Recombinant FVIII
    Figure 45. Manufacturing Process Analysis of Recombinant FVIII
    Figure 46. Recombinant FVIII Industrial Chain Analysis
    Figure 47. Channels of Distribution
    Figure 48. Distributors Profiles
    Figure 49. Bottom-up and Top-down Approaches for This Report
    Figure 50. Data Triangulation
    Figure 51. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bayer
Baxter
Comirnaty
Novo Nordisk
Green Cross
Sinocelltech
Frequently Asked Questions
Recombinant FVIII report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Recombinant FVIII report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Recombinant FVIII report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Methyl Maltol

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More